Global Sexually Transmitted Diseases (STD) Testing Market -2024-2031
Global Sexually Transmitted Diseases (STD) Testing Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2024-2031.
A sexually transmitted disease is a serious condition that can develop after having sex. Common STD symptoms include itching and burning around the genital area. Tests for sexually transmitted diseases include blood, urine, or swab tests and the choice of test can depend on the symptoms and the condition.
Common sexually transmitted diseases include syphilis, chlamydia, gonorrhea, human immunodeficiency virus/AIDS, and trichomoniasis. Some STDs like the human immunodeficiency virus (HIV) have no cure and can be life-threatening without treatment.
Market Dynamics
Increasing prevalence of STDs
The increasing number of sexually transmitted cases acts as a significant driver for market growth. Sexually transmitted diseases (STDs) are very common and millions of new infections occur every year globally. STDs pass from one person to another through vaginal, oral and anal sex.
For instance, according to a World Health Organization (WHO) report published in July 2023, more than 1 million sexually transmitted infections are acquired every day worldwide. An estimated 374 million new STD infections occur annually.
Additionally, The World Health Organization has estimated that every year in Africa there are 3.5 million cases of syphilis, 15 million cases of chlamydial disease, 16 million cases of gonorrhea, and 30 million cases of trichomoniasis.
Furthermore, the global sexually transmitted diseases (STD) testing market is driven by various factors like increasing awareness of STDs, and new product launches are expected to drive the market in the forecast period.
Social stigma and lack of awareness
Social stigma and embarrassment faced by individuals can hamper market growth. People are reluctant to seek STD testing which leads to underdiagnosis of a serious condition. Also, a lack of awareness regarding various sexually transmitted infections can hamper the market growth.
For more details on this report – Request for Sample
Segment Analysis
The global sexually transmitted diseases (STD) testing market is segmented based on product type, disease type, location of test, end users and region.
Reagents and kits accounted for approximately 63.4% of the market share
STD kits allow users to choose between different STD panels, each including a different set of tests. Reagents and kits are expected to hold the largest market share over the period forecast owing to increasing the need for STD testing kits and new product launches.
For instance, in February 2023, Mylab Discovery Solutions launched a range of rapid test kits for STDs namely HIV, HCV, and Syphilis for detection at the point of care
Additionally, in August 2023, iHealth Labs, Inc. launched its Home Collection Kit for HIV and syphilis testing. This kit delivers reliable results of up to 99.9% sensitivity for HIV and 99.5% for syphilis.
Geographical Analysis
North America is expected to hold a significant position in the global sexually transmitted diseases (STD) testing market share
The global sexually transmitted diseases (STD) testing market is segmented into North America, Europe, Asia Pacific, South America, Middle East and Africa.
North America has maintained a significant market proportion due to factors such as rising healthcare expenditure, rising awareness, and STD testing launches, this trend is anticipated to continue throughout the forecast period.
For instance, in June 2022, the Centers for Disease Control and Prevention recommended and issued guidelines for screening of sexually transmitted diseases in order to create awareness towards screening programs for STDs and the increasing burden of STDs across the globe.
Additionally, in May 2023, US BioTek Laboratories launched at-home STI Testing by offering laboratory STI panels, including those for PrEP that can be conveniently self-collected in the comfort of a patient's own home.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global sexually transmitted diseases (STD) testing market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, device launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the sexually transmitted diseases (STD) testing market was moderately affected over the forecast period.
Market Segmentation
By Product Type
• Reagents and Kits
• Instruments
By Disease Type
• Syphilis
• Chlamydia
• Gonorrhea
• Human Immunodeficiency Virus/AIDS
• Trichomoniasis
• Others
By Location of Test
• Laboratory Testing
• Point of Care Testing
By End Users
• Hospitals
• Clinics
• Diagnostic Centers
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Roche Diagnostics Corporation, Bio-Rad Laboratories, Hologic, Inc., Merck and Company Inc., Becton Dickinson & Company, Cepheid, Inc., Danaher Corporation, Affymetrix, Inc., DiaSorin, Abbott Laboratories among others.
Key Developments
• In May 2022, Medmira Inc. received a CE mark for its Multiplo Complete Syphilis (TP/nTP) Antibody Test (Multiplo TP/nTP). This approval enables the company to further strengthen its product offering in all markets accepting the CE mark.
Why Purchase the Report?
• To visualize the global sexually transmitted diseases (STD) testing market segmentation based on product type, disease type, location of test, end users and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of sexually transmitted diseases (STD) testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global sexually transmitted diseases (STD) testing market report would provide approximately 61 tables, 63 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Disease Type
- 3.3. Snippet by Location of Test
- 3.4. Snippet by End Users
- 3.5. Snippet by Region
- 4. Market Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing prevalence of STDs
- 4.1.1.2. YY
- 4.1.2. Restraints
- 4.1.2.1. Social stigma and lack of awareness
- 4.1.2.2. YY
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. DMI Opinion
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Product Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
- 7.2. Reagents and Kits *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Instruments
- 8. By Disease Type
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 8.1.2. Market Attractiveness Index, By Disease Type
- 8.2. Syphilis *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Chlamydia
- 8.4. Gonorrhea
- 8.5. Human Immunodeficiency Virus/AIDS
- 8.6. Trichomoniasis
- 8.7. Others
- 9. By Location of Test
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 9.1.2. Market Attractiveness Index, By Location of Test
- 9.2. Laboratory Testing *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Point of Care Testing
- 10. By End Users
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 10.1.2. Market Attractiveness Index, By End Users
- 10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Clinics
- 10.4. Diagnostic Centers
- 10.5. Others
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. UK
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.5.7.1. China
- 11.5.7.2. India
- 11.5.7.3. Japan
- 11.5.7.4. Australia
- 11.5.7.5. Rest of Asia-Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Location of Test
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Roche Diagnostics Corporation
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
- 13.2. Bio-Rad Laboratories
- 13.3. Hologic, Inc.
- 13.4. Merck and Company Inc
- 13.5. Becton Dickinson & Company
- 13.6. Cepheid, Inc.
- 13.7. Danaher Corporation
- 13.8. Affymetrix, Inc.
- 13.9. DiaSorin
- 13.10. Abbott Laboratories
- LIST NOT EXHAUSTIVE
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook